Screener
AbbVie ABBV Cumulative Cost Basis
Cumulative Cost Basis at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The source filing: AbbVie’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
FAQ
- What is AbbVie's cumulative cost basis?
- AbbVie (ABBV) reported cumulative cost basis of $13.73B in Q1 2026.
- How has AbbVie's cumulative cost basis changed year-over-year?
- AbbVie's cumulative cost basis increased by 9.2% year-over-year, from $12.57B to $13.73B.
- What is the long-term trend for AbbVie's cumulative cost basis?
- Over 5 years (2020 to 2025), AbbVie's cumulative cost basis has grown at a 4.5% compound annual growth rate (CAGR), from $10.86B to $13.53B.
Ask your AI about AbbVie's cumulative cost basis.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude